Variant report

Variant	esv3410581
Chromosome Location	chr15:30259685-30262533
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:45)
CpG islands
(count:366)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:45 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr15:30260917-30261293	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD2	chr15:30260900-30260917	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD2	chr15:30261185-30261505	H1-hESC	embryonic stem cell:	n/a	n/a
4	CREB1	chr15:30260434-30261180	A549	lung:	n/a	n/a
5	CTCF	chr15:30260674-30260675	MCF-7	breast:	n/a	n/a
6	CTCF	chr15:30260638-30260726	A549	lung:	n/a	n/a
7	E2F6	chr15:30260300-30261650	A549	lung:	n/a	chr15:30260847-30260856 chr15:30261247-30261256
8	E2F6	chr15:30260305-30260930	H1-hESC	embryonic stem cell:	n/a	chr15:30260847-30260856
9	E2F6	chr15:30260494-30261587	H1-hESC	embryonic stem cell:	n/a	chr15:30260847-30260856 chr15:30261247-30261256
10	E2F6	chr15:30260775-30261151	A549	lung:	n/a	chr15:30260847-30260856
11	E2F6	chr15:30261203-30261723	H1-hESC	embryonic stem cell:	n/a	chr15:30261247-30261256
12	GATA3	chr15:30259671-30260052	SH-SY5Y	brain:	n/a	n/a
13	GTF2F1	chr15:30260889-30260973	H1-hESC	embryonic stem cell:	n/a	n/a
14	MAX	chr15:30260430-30260777	H1-hESC	embryonic stem cell:	n/a	chr15:30260559-30260569 chr15:30260666-30260673
15	MAX	chr15:30260425-30261126	H1-hESC	embryonic stem cell:	n/a	chr15:30260559-30260569 chr15:30260666-30260673
16	MAX	chr15:30261250-30261706	H1-hESC	embryonic stem cell:	n/a	n/a
17	MAX	chr15:30260440-30261636	ECC-1	luminal epithelium:	n/a	chr15:30260559-30260569 chr15:30260666-30260673
18	MAX	chr15:30261186-30261658	A549	lung:	n/a	n/a
19	MAX	chr15:30260292-30260842	A549	lung:	n/a	chr15:30260559-30260569 chr15:30260666-30260673
20	MAX	chr15:30261155-30261488	H1-hESC	embryonic stem cell:	n/a	n/a
21	MAX	chr15:30260307-30261726	A549	lung:	n/a	chr15:30260559-30260569 chr15:30260666-30260673
22	MAX	chr15:30260203-30261869	A549	lung:	n/a	chr15:30260559-30260569 chr15:30260666-30260673
23	MAX	chr15:30260396-30260786	H1-hESC	embryonic stem cell:	n/a	chr15:30260559-30260569 chr15:30260666-30260673
24	MAX	chr15:30261137-30261638	H1-hESC	embryonic stem cell:	n/a	n/a
25	MYC	chr15:30261235-30261238	MCF-7	breast:	n/a	n/a
26	MYC	chr15:30260629-30260990	MCF-7	breast:	n/a	chr15:30260666-30260673
27	MYC	chr15:30261120-30261228	MCF-7	breast:	n/a	n/a
28	POLR2A	chr15:30260999-30261387	A549	lung:	n/a	n/a
29	POLR2A	chr15:30261051-30261079	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr15:30260888-30260950	H1-hESC	embryonic stem cell:	n/a	n/a
31	POLR2A	chr15:30260729-30261278	H1-neurons	neurons:	n/a	n/a
32	POLR2A	chr15:30260515-30261409	A549	lung:	n/a	n/a
33	POLR2A	chr15:30261158-30261379	ECC-1	luminal epithelium:	n/a	n/a
34	POLR2A	chr15:30261008-30261276	A549	lung:	n/a	n/a
35	POLR2A	chr15:30260823-30261245	H1-neurons	neurons:	n/a	n/a
36	POLR2A	chr15:30260534-30261426	A549	lung:	n/a	n/a
37	POLR2A	chr15:30261362-30261411	MCF10A-Er-Src	breast:	n/a	n/a
38	POLR2A	chr15:30260604-30260733	Gliobla	brain:	n/a	n/a
39	POLR2A	chr15:30260606-30260777	A549	lung:	n/a	n/a
40	RAD21	chr15:30260817-30260929	IMR90	lung:	n/a	n/a
41	TBP	chr15:30260428-30260977	H1-hESC	embryonic stem cell:	n/a	n/a
42	TBP	chr15:30261249-30261654	H1-hESC	embryonic stem cell:	n/a	n/a
43	YY1	chr15:30260771-30261033	H1-hESC	embryonic stem cell:	n/a	chr15:30260851-30260865 chr15:30260848-30260862
44	ZBTB7A	chr15:30260454-30260929	ECC-1	luminal epithelium:	n/a	n/a
45	ZNF143	chr15:30260465-30260953	H1-hESC	embryonic stem cell:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:30261418-30261468	HepG2	liver:	n/a
2	chr15:30260459-30260509	GM12892	blood:	n/a
3	chr15:30260973-30261023	AG04450	lung:	fetal
4	chr15:30260973-30261023	IMR90	lung:	fetal
5	chr15:30261418-30261468	NT2-D1	testis:	n/a
6	chr15:30260534-30260584	HCT-116	colon:	n/a
7	chr15:30261393-30261443	H1-hESC	embryonic stem cell:	embryo
8	chr15:30261418-30261468	A549	lung:	n/a
9	chr15:30261393-30261443	T-47D	breast:	n/a
10	chr15:30261418-30261468	AG04450	lung:	fetal
11	chr15:30260973-30261023	GM19239	blood:	n/a
12	chr15:30261393-30261443	Jurkat	blood:	n/a
13	chr15:30261418-30261468	AG09319	gingival:	n/a
14	chr15:30260459-30260509	MCF-7	breast:	n/a
15	chr15:30261393-30261443	GM12891	blood:	n/a
16	chr15:30261379-30261429	HCM	heart:	n/a
17	chr15:30261393-30261443	Caco-2	colon:	n/a
18	chr15:30260534-30260584	IMR90	lung:	fetal
19	chr15:30261393-30261443	HCPEpiC	choroid plexus:	n/a
20	chr15:30261379-30261429	HCPEpiC	choroid plexus:	n/a
21	chr15:30261393-30261443	ProgFib	skin:	n/a
22	chr15:30260459-30260509	H1-hESC	embryonic stem cell:	embryo
23	chr15:30260459-30260509	NB4	blood:	n/a
24	chr15:30260534-30260584	LNCaP	prostate:	n/a
25	chr15:30260459-30260509	IMR90	lung:	fetal
26	chr15:30261379-30261429	SAEC	small airway:	n/a
27	chr15:30260534-30260584	SAEC	small airway:	n/a
28	chr15:30261379-30261429	BJ	skin:	n/a
29	chr15:30260459-30260509	NHBE	bronchial:	n/a
30	chr15:30260973-30261023	Jurkat	blood:	n/a
31	chr15:30260534-30260584	NHDF-neo	bronchial:	n/a
32	chr15:30260459-30260509	HCF	heart:	n/a
33	chr15:30260534-30260584	HEEpiC	esophagus:	n/a
34	chr15:30260459-30260509	HNPCEpiC	eye:	n/a
35	chr15:30261379-30261429	Hela-S3	cervix:	n/a
36	chr15:30261393-30261443	HL-60	blood:	n/a
37	chr15:30261379-30261429	ECC-1	luminal epithelium:	n/a
38	chr15:30261418-30261468	HCF	heart:	n/a
39	chr15:30261418-30261468	BE2_C	brain:	n/a
40	chr15:30261393-30261443	AoSMC	blood vessel:	n/a
41	chr15:30260534-30260584	PANC-1	pancreas:	n/a
42	chr15:30261379-30261429	NHBE	bronchial:	n/a
43	chr15:30261379-30261429	H1-hESC	embryonic stem cell:	embryo
44	chr15:30261418-30261468	ovcar-3	ovarian:	n/a
45	chr15:30260534-30260584	K562	blood:	n/a
46	chr15:30261393-30261443	HCT-116	colon:	n/a
47	chr15:30261393-30261443	Hela-S3	cervix:	n/a
48	chr15:30261379-30261429	AG04450	lung:	fetal
49	chr15:30261418-30261468	AG09309	skin:	n/a
50	chr15:30260973-30261023	NT2-D1	testis:	n/a

No data

Variant related genes	Relation type
TJP1	TF binding region
TJP1	CpG island

Extended variants
information (count: 107 )
Associated
traits (count: 151 )

Variant overlapped rSNPs/rCNVs (count:107 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs566439656	chr15:30259693-30259694	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs528920416	chr15:30259734-30259735	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs186806109	chr15:30259782-30259783	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs548658097	chr15:30259787-30259788	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs568836124	chr15:30259789-30259790	Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs374558951	chr15:30259865-30259866	Weak transcription Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs537715867	chr15:30259876-30259877	Weak transcription Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs569506339	chr15:30259877-30259878	Weak transcription Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs78331763	chr15:30259883-30259884	Weak transcription Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs547181558	chr15:30259919-30259920	Weak transcription Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs386782588	chr15:30259921-30259922	Weak transcription Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs8035651	chr15:30259923-30259924	Weak transcription Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs553472457	chr15:30259958-30259959	Weak transcription Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs573215469	chr15:30259977-30259978	Weak transcription Bivalent/Poised TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs557299823	chr15:30260006-30260007	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
16	rs142713203	chr15:30260012-30260013	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
17	rs555769363	chr15:30260051-30260052	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
18	rs8042079	chr15:30260097-30260098	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs544953944	chr15:30260176-30260177	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
20	rs67030144	chr15:30260190-30260191	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs533619761	chr15:30260199-30260200	Weak transcription Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
22	rs540457748	chr15:30260241-30260242	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs368643770	chr15:30260262-30260263	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs560200405	chr15:30260269-30260270	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs1403254	chr15:30260285-30260286	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs572521140	chr15:30260298-30260299	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs562180705	chr15:30260343-30260344	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs539922715	chr15:30260369-30260370	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs561473872	chr15:30260371-30260372	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs187590272	chr15:30260435-30260436	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs142637938	chr15:30260484-30260485	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs2222420	chr15:30260500-30260501	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
33	rs76174223	chr15:30260508-30260509	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs547227982	chr15:30260569-30260570	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs573778144	chr15:30260580-30260581	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs544119941	chr15:30260679-30260680	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs562712644	chr15:30260680-30260681	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs8040962	chr15:30260724-30260725	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs575734627	chr15:30260757-30260758	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs12899255	chr15:30260761-30260762	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs538238123	chr15:30260770-30260771	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs558526223	chr15:30260825-30260826	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
43	rs113157556	chr15:30260827-30260828	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
44	rs578151217	chr15:30260887-30260888	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
45	rs141536951	chr15:30260983-30260984	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
46	rs560448557	chr15:30261102-30261103	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs62014524	chr15:30261103-30261104	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs574163749	chr15:30261105-30261106	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs533032228	chr15:30261127-30261128	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs562241747	chr15:30261204-30261205	Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:151)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
HDAC8	0	CNVD
NIPBL	0	CNVD
RAD21	0	CNVD
SMC1A	0	CNVD
SMC3	0	CNVD
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prader-willi syndrome	21504564	CNVD
The inv dup or idic syndrome	19019226	CNVD
Prader-willi syndrome	21233802	CNVD
Angelman syndrome	16617304	CNVD
Angelman syndrome	20970697	CNVD
Autism	22958593	CNVD
Prader-willi syndrome	16617304	CNVD
Prader-willi syndrome	18923514	CNVD
Prader-willi syndrome	20970697	CNVD
Angelman syndrome	16183798	CNVD
Angelman syndrome	18923514	CNVD
Prader-willi syndrome	22241247	CNVD
Epilepsy	20970697	CNVD
Autism	20970697	CNVD
Autism	19935738	CNVD
Autism	22930557	CNVD
Autism	19966786	CNVD
Autism	18923514	CNVD
Autism	18925931	CNVD
Autism	18835857	CNVD
Prader-willi syndrome	18835857	CNVD
Prader-willi syndrome	22152151	CNVD
Autism	22241247	CNVD
15q-syndrome	21725066	CNVD
Prader-willi syndrome	21503198	CNVD
Autism	21956041	CNVD
Prader-willi syndrome	16760730	CNVD
Prader-willi syndrome	22470819	CNVD
prenatal diagnosis	20453657	CNVD
Prader-willi syndrome	17867985	CNVD
Angelman syndrome	21072004	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Prader-willi syndrome	18781185	CNVD
Melanoma	18172304	CNVD
Autism	17322880	CNVD
Prader-willi syndrome	19329560	CNVD
Autism	17999366	CNVD
Autism	17901113	CNVD
Neurodevelopmental disorder	17015230	CNVD
Autism	18414403	CNVD
Neurocytoma	17123091	CNVD
Mental retardation	18923513	CNVD
Colorectal cancer	16774939	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Intellectual disability	22102821	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Schizophrenia	19197363	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Angelman syndrome	18787571	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Abnormal corpus callosum	21572526	CNVD
idiopathic generalized epilepsy	19843651	CNVD
Autism	20531469	CNVD
Neuropsychiatric disorder	20506139	CNVD
Austim spectrum disorder	21302340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Mental retardation	17124404	CNVD
Autism	19204725	CNVD
Schizophrenia	19204725	CNVD
Schizophrenia	19149910	CNVD
Schizophrenia	20967226	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Autism	19843651	CNVD
Schizophrenia	19843651	CNVD
Schizophrenia	23813976	CNVD
Cognitive impairment	21505072	CNVD
Autism	22543975	CNVD
small cell lung cancer	20016488	CNVD
Autism	22495309	CNVD
Schizophrenia	20388499	CNVD
Epilepsy	22499536	CNVD
Schizophrenia	22499536	CNVD
Schizophrenia	18923514	CNVD
Bipolar disorder	19114987	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Schizophrenia	21285140	CNVD
Schizophrenia	20553308	CNVD
Schizophrenia	21956041	CNVD
Schizophrenia	20970697	CNVD
Mental retardation	19951919	CNVD
Mental retardation	21956041	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Autism	21269290	CNVD
Intellectual disability	21269290	CNVD
Schizophrenia	21269290	CNVD
Colorectal cancer	21128281	CNVD
Epilepsy	19289393	CNVD
Epilepsy	20643615	CNVD
Mental retardation	19289393	CNVD
Mental retardation	20152051	CNVD
Schizophrenia	19289393	CNVD
dysmorphic features	19289393	CNVD
idiopathic epilepsies	19341504	CNVD
idiopathic generalized epilepsy	19592580	CNVD
idiopathic generalized epilepsy	19136953	CNVD
Autism	22094647	CNVD
Developmental delay	19898479	CNVD
Mental retardation	18278044	CNVD
Mental retardation	19898479	CNVD
Prader-willi syndrome	18854863	CNVD
Schizophrenia	19855392	CNVD
Ovarian cancer	22174824	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:189 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:30232600-30260400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr15:30255600-30260000	Weak transcription	Cortex derived primary cultured neurospheres	brain
3	chr15:30257200-30260400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr15:30259000-30259800	Enhancers	Brain Substantia Nigra	brain
5	chr15:30259200-30262200	Active TSS	Brain Anterior Caudate	brain
6	chr15:30259400-30259800	Flanking Active TSS	Brain Cingulate Gyrus	brain
7	chr15:30259600-30259800	Flanking Active TSS	Brain Hippocampus Middle	brain
8	chr15:30259600-30259800	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
9	chr15:30259600-30259800	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
10	chr15:30259600-30259800	Bivalent Enhancer	Fetal Brain Male	brain
11	chr15:30259600-30260400	Enhancers	Liver	Liver
12	chr15:30259600-30262000	Active TSS	Brain Angular Gyrus	brain
13	chr15:30259800-30260600	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr15:30259800-30260600	Bivalent/Poised TSS	Fetal Brain Male	brain
15	chr15:30259800-30261600	Active TSS	Brain Substantia Nigra	brain
16	chr15:30259800-30261800	Active TSS	Brain Cingulate Gyrus	brain
17	chr15:30259800-30261800	Active TSS	Brain Hippocampus Middle	brain
18	chr15:30259800-30262000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
19	chr15:30259800-30262600	Active TSS	Brain Inferior Temporal Lobe	brain
20	chr15:30260000-30260200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
21	chr15:30260000-30260200	Enhancers	Cortex derived primary cultured neurospheres	brain
22	chr15:30260000-30260200	Enhancers	HMEC	breast
23	chr15:30260000-30260400	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
24	chr15:30260000-30261400	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
25	chr15:30260200-30260400	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr15:30260200-30260400	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
27	chr15:30260200-30260400	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
28	chr15:30260200-30260400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
29	chr15:30260200-30260400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr15:30260200-30260400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
31	chr15:30260200-30260400	Bivalent Enhancer	Adipose Nuclei	Adipose
32	chr15:30260200-30260400	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
33	chr15:30260200-30260400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
34	chr15:30260200-30260400	Flanking Bivalent TSS/Enh	A549	lung
35	chr15:30260200-30260600	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
36	chr15:30260200-30260600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
37	chr15:30260200-30260600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
38	chr15:30260200-30260600	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr15:30260200-30260600	Bivalent Enhancer	Colon Smooth Muscle	Colon
40	chr15:30260200-30260600	Bivalent/Poised TSS	Duodenum Smooth Muscle	Duodenum
41	chr15:30260200-30260600	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
42	chr15:30260200-30260600	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
43	chr15:30260200-30260600	Flanking Bivalent TSS/Enh	Stomach Smooth Muscle	stomach
44	chr15:30260200-30260600	Flanking Active TSS	HMEC	breast
45	chr15:30260200-30260800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
46	chr15:30260200-30260800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr15:30260200-30261000	Bivalent/Poised TSS	NH-A	brain
48	chr15:30260200-30261200	Bivalent/Poised TSS	HUVEC	blood vessel
49	chr15:30260200-30261400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
50	chr15:30260200-30261400	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links